In clinical breast cancer specimens, a frequent upregulation and co-localization of TN-C with the mesenchymal marker vimentin was observed at the invasive fronts of cancers in those cells having a more scattered and mesenchymal-like morphology. This evidence concerns the gene TNC and breast cancer.